Cart
sales@molnova.com
5alpha-Cholestan-3-one
CAS No. 566-88-1
5alpha-Cholestan-3-one( —— )
Catalog No. M18822 CAS No. 566-88-1
5alpha-Cholestan-3-one(5aCh3) is an intermediate product in cholesterol metabolism, which is elevated in the case of cerebrotendinous xanthomatosis.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 10MG | 49 | In Stock |
|
| 25MG | 76 | In Stock |
|
| 50MG | 110 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product Name5alpha-Cholestan-3-one
-
NoteResearch use only, not for human use.
-
Brief Description5alpha-Cholestan-3-one(5aCh3) is an intermediate product in cholesterol metabolism, which is elevated in the case of cerebrotendinous xanthomatosis.
-
Description5alpha-Cholestan-3-one(5aCh3) is an intermediate product in cholesterol metabolism, which is elevated in the case of cerebrotendinous xanthomatosis. Within the cell, It is primarily located in the membrane (predicted from logP).
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number566-88-1
-
Formula Weight386.67
-
Molecular FormulaC27H46O
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?Ethanol : 14.29 mg/mL (36.96 )
-
SMILESCC(C)CCC[C@@H](C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]1[C@H]2CC[C@@H]2[C@@]1(CCC(=O)C2)C)C
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Kasimov MR, et al. Biochim Biophys Acta. 2015 May;1851(5):674-85.
molnova catalog
related products
-
Aristolone
Aristolone has potential anti-cancer activity.
-
Methylamine hydrochl...
Methylamine occurs endogenously from amine catabolism and its tissue levels increase in some pathological conditions including diabetes.
-
Pomalidomide-C3-NH2 ...
Pomalidomide-C3-NH2 hydrochloride is a synthesized E3 ligase ligand-linker conjugate that incorporates the Pomalidomide based CRBN ligand and linker used in PROTAC technology.
